Skip to main content

Copper-Rich Metallothionein Polymers During the Development of Fulminant Hepatitis in LEC Rats

Effect of D-Penicillamine

  • Chapter
Handbook of Copper Pharmacology and Toxicology

Abstract

The progressive accumulation of copper in hepatocytes of humans and animals may lead to hepatocellular necrosis (1–3). In Wilson’s disease, an inherited disorder of copper metabolism in humans, the excretion of copper into bile is impaired. The phenotype of the disease is caused by a mutation of the ATP7B gene leading to a nonfunctioning gene product, a copper-transporting P-type ATPase (4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sternlieb, I. (1980) Copper and the liver. Gastroenterology 78, 1615–1628.

    PubMed  CAS  Google Scholar 

  2. Schilsky, M. L. and Sternlieb, I. (1993) Animal models of copper toxicosis. Anim. Mod. Liver Res. 37, 357–377.

    CAS  Google Scholar 

  3. Pandit, A. N. and Bhave, S. A. (1983) Copper and Indian childhood cirrhosis. Indian Pediatr. 20, 893–899.

    PubMed  CAS  Google Scholar 

  4. Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R., and Cox, D. W. (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genet. 5, 327–337.

    Article  PubMed  CAS  Google Scholar 

  5. Yoshida, M. C., Masuda, R., Sasaki, M., Takeichi, N., Kobayashi, H., Dempo, K., et al. (1987) New mutation causing hereditary hepatitis in the laboratory rat. J. Hered. 78, 361–365.

    PubMed  CAS  Google Scholar 

  6. Li, Y., Togashi, Y., Sato, S., Emoto, T., Kang, J. H., Takeichi, N., et al. (1991) Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. J. Clin. Invest. 87, 1858–1861.

    Article  PubMed  CAS  Google Scholar 

  7. Wu, J., Forbes, J. R., Chen, H. S., and Cox, D. W. (1994) The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nature Genet. 7, 541–545.

    Article  PubMed  CAS  Google Scholar 

  8. Sasaki, M., Yoshida, M. C., Kagami, K., Takeichi, N., Kobayashi, H., Dempo, K., et al. (1985) Spontaneous hepatitis in an inbred strain of Long-Evans rats. Rat News Lett. 14, 4–6.

    Google Scholar 

  9. Takeichi, N., Kobayashi, H., Yoshida, M. C., Sasaki, M., Dempo, K., and Mori, M. (1988) Spontaneous hepatitis in Long-Evans rats: a potential animal model for fulminant hepatitis in man. Acta Pathol. Jpn. 38, 1369–1375.

    PubMed  CAS  Google Scholar 

  10. Togashi, Y., Li, Y., Jong-Hon, K., Takeichi, N., Fujioka, Y., Nagashima, K., et al. (1992) 6-Penicillamine prevents the development of hepatitis in Long-Evans Cinnamon rats with abnormal copper metabolism. Hepatology 15, 82–87.

    Google Scholar 

  11. Jong-Hon, K., Togashi, Y., Kasai, H., Hosokawa, M., and Takeichi, N. (1993) Prevention of spontaneous hepatocellular carcinoma on Long-Evans Cinnamon rats with hereditary hepatitis by the administration of o-penicillamine. Hepatology 18, 614–620.

    PubMed  CAS  Google Scholar 

  12. Walshe, J. M. (1956) Penicillamine: a new oral therapy for Wilson’s disease. Am. J. Med. 2, 487–495.

    Article  Google Scholar 

  13. Parkes, D. (1984) Wilson’s disease. Br. Med. J. 288, 1180–1181.

    Article  CAS  Google Scholar 

  14. Lingam, S., Wilson, J., Nazer, H., and Mowat, A. P. (1987) Neurological abnormalities in Wilson’s disease are reversible. Neuropediatrics 18, 11–12.

    Article  PubMed  CAS  Google Scholar 

  15. Hanaichi, T., Kidokoro, R., Hayashi, H., and Sakamoto, N. (1984) Electron probe X-ray analysis on human hepatocellular lysosomes with copper deposits: copper binding to a thiol-protein in lysosomes. Lab. Invest. 51, 592–597.

    PubMed  CAS  Google Scholar 

  16. Lerch, K., Johnson, G. F., Grushoff, P. S., and Sternlieb, I. (1985) Canine hepatic lysosomal copper protein: identification as metallothionein. Arch. Biochem. Biophys. 243, 108–114.

    Article  PubMed  CAS  Google Scholar 

  17. Johnson, G. F., Morell, A. G., Stockert, R. J., and Sternlieb, I. (1981) Hepatic lysosomal copper protein in dogs with an inherited copper toxicosis. Hepatology 1, 243–248.

    Article  PubMed  CAS  Google Scholar 

  18. Klein, D., Lichtmannegger, J., Heinzmann, U., Müller-Höcker, J., Michaelsen, S., and Summer, K. H. (1998) Association of copper to metallothionein in hepatic lysosomes of Long-Evans cinnamon (LEC) rats during the development of hepatitis. Eur. J. Clin. Invest. 28, 302–310.

    Article  PubMed  CAS  Google Scholar 

  19. Klein, D., Bartsch, R., and Summer, K. H. (1990) Quantitation of Cu-containing metallothionein by a Cd-saturation method. Anal. Biochem. 189, 35–39.

    Article  PubMed  CAS  Google Scholar 

  20. Kato, N., Nakamura, M., and Uchiyama, T. (1999) 1H NMR studies of the reactions of copper(I) and copper(II) with Dpenicillamine and glutathione. J. Inorg. Biochem. 75, 117–121.

    Google Scholar 

  21. Klein, D., Michaelsen, S., Sato, S., Luz, A., Stampfl, A., and Summer, K. H. (1987) Binding of copper to metallothionein in tissues of the LEC rat with inherited abnormal copper accumulation. Arch. Toxicol. 71, 340–343.

    Article  Google Scholar 

  22. Goldfischer, S. and Sternlieb, I. (1968) Changes in the distribution of hepatic copper in relation to the progression of Wilson’s disease (hepatolenticular degeneration). Am. J. Pathol. 53, 883–901.

    PubMed  CAS  Google Scholar 

  23. Goldfischer, S., Popper, H., and Sternlieb, I. (1980) The significance of variations in distribution of copper in liver disease. Am. J. Pathol. 99, 715–723.

    PubMed  CAS  Google Scholar 

  24. Lindquist, R. R. (1968) Studies on the pathogenesis of hepatolenticular degeneration. III. The effect of copper on rat liver lysosomes. Am. J. Pathol. 53, 903–927.

    PubMed  CAS  Google Scholar 

  25. Myers, B. M., Prendergast, F. G., Holman, R., Kuntz, S. M., and LaRusso, N. F. (1993) Alterations in hepatocyte lysosomes in experimental hepatic copper overload in rats. Gastroenterology 105, 1814–1823.

    PubMed  CAS  Google Scholar 

  26. Kumaratilake, J. S. and McHowell, J. C. (1989) Lysosomes in the pathogenesis of liver injury in chronic copper poisoned sheep: An ultrastructural and morphometric study. J. Compar. Pathol. 100, 381–390.

    Article  CAS  Google Scholar 

  27. Mehra, R. K. and Bremner, I. (1985) Studies on the metabolism of rat liver copper-metallothionein. Biochem. J. 227, 903–908.

    PubMed  CAS  Google Scholar 

  28. Hunziker, P. E. (1991) Metal removal from mammalian metallothioneins. Methods Enzymol. 205, 451–452.

    Article  PubMed  CAS  Google Scholar 

  29. Bremner, I. and Mehra, R. K. (1983) Metallothionein: some aspects of its structure and function with special regard to its involvement in copper and zinc metabolism. Chemica Scripta 21, 117–121.

    CAS  Google Scholar 

  30. Presta, A., Green, A. R., Zelazowski, A., and Stillman, M. J. (1995) Copper binding to rabbit liver metallothionein. Formation of a continuum of copper(I)-thiolate stoichiometric species. Eur. J. Biochem. 227, 226–240.

    Article  PubMed  CAS  Google Scholar 

  31. Li, H. and Otvos, J. D. (1996) 111Cd NMR studies of the domain specificity of Ag* and Cu’ binding to metallothionein. Biochemistry 35, 13, 929–13, 936.

    Google Scholar 

  32. Sumi, Y., Kawahara, S., Kikuchi, Y., Sawada, J. I., Suzuki, T., and Suzuki, K. T. (1993) Histochemical and immunohistochemical localization of copper, iron and metallothionein in the liver and kidney of LEC rats. Acta Histochem. Cytochem. 26, 5–9.

    Article  CAS  Google Scholar 

  33. Scheinberg, I. H. and Sternlieb, I. (1984) Wilson’s disease, in Major Problems in Internal Medicine ( Smith, L. H., Jr., ed.), W. B. Saunders, Philadelphia.

    Google Scholar 

  34. Sauer, J. M., Waalkes, M. P., Hooser, S. B., Kuester, R. K., McQueen, C. A., and Sipes, I. G. (1997) Suppression of Kupffer cell function prevents cadmium induced hepatocellular necrosis in the male Sprague-Dawley rat. Toxicology 121, 155–164.

    Article  PubMed  CAS  Google Scholar 

  35. Edwards, M. J., Keller, B. J., Kauffman, F. C., and Thurman, R. G. (1993) The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol. Appl. Pharmacol. 119, 275–279.

    Article  PubMed  CAS  Google Scholar 

  36. Gibbs, K. and Walshe, J. M. (1990) Liver copper concentration in Wilson’s disease: effect of treatment with “anti-copper” agents. J. Gastroenterol. Hepatol. 5, 520–524.

    Article  Google Scholar 

  37. Scheinberg, I. H., Sternlieb, I., Schilsky, M., and Stockert, R. J. (1987) Penicillamine may detoxify copper in Wilson’s disease. Lancet 2, 95.

    Article  PubMed  CAS  Google Scholar 

  38. Goering, P. L., Tandon, K., and Klaassen, C. D. (1985) Induction of hepatic metallothionein in mouse liver following administration of chelating agents. Toxicol. Appl. Pharmacol. 80, 467–472.

    Article  PubMed  CAS  Google Scholar 

  39. Heilmaier, H. E., Jiang, J. L., Greim, H., Schramel, P., and Summer, K. H. (1986) D-penicillamine induces rat hepatic metallothionein. Toxicology 42, 23–31.

    Article  PubMed  CAS  Google Scholar 

  40. Vallon, J. J. and Badinand, A. (1968) A polarographic study of the redox and complex-forming reactions of penicillamine, N-acetylpenicillamine and copper (I). Anal. Chim. Acta 42, 445–454.

    Article  PubMed  CAS  Google Scholar 

  41. Joyce, D. A. (1989) n-Penicillamine pharmacokinetics and pharmacodynamics in man. Pharmac. Ther. 42, 405–427.

    Google Scholar 

  42. McQuaid, A. and Mason, J. (1990) A comparison of the effects of penicillamine, trientine, and trithiomolybdate on (355)-labeled metallothionein in vitro; implications for Wilson’s disease therapy. J. Inorg. Biochem. 41, 87–92.

    Article  Google Scholar 

  43. McQuaid, A., Lamand, M., and Mason, J. (1992) The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilsons’s disease and arthritis therapy. J. Lab. Clin. Med. 119, 744–750.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Klein, D., Lichtmannegger, J., Summer, K.H. (2002). Copper-Rich Metallothionein Polymers During the Development of Fulminant Hepatitis in LEC Rats. In: Massaro, E.J. (eds) Handbook of Copper Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-288-3_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-288-3_28

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-266-7

  • Online ISBN: 978-1-59259-288-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics